Name: Biotechnology and Crispr (en Inglés)
SKU: 63244970
Price: 178430.00 CLP
Availability: InStock
Author: Joe Figel; Christopher Clark; Keryn Gedan
ISBN: 9781787152854

portada Biotechnology and Crispr (en Inglés)

Formato

Libro Físico

Editorial

Kruger Brentt Publisher Uk. Ltd.

Autor

Joe Figel; Christopher Clark; Keryn Gedan

Idioma

Inglés

N° páginas

420

Encuadernación

Tapa Dura

ISBN13

9781787152854

Biotechnology and Crispr (en Inglés)

Joe Figel; Christopher Clark; Keryn Gedan (Autor) · Kruger Brentt Publisher Uk. Ltd. · Tapa Dura

Libro Nuevo Importado

Envío: 12 a 16 días háb.

$ 356.860$ 178.430

-50%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan más de 100 unidades

$ 178.430

Llega entre el 06 Oct y el 13 Oct a Santiago, Región Metropolitana. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Biotechnology and Crispr (en Inglés)"

Introduction to Biotechnology: Comprehensive overview of biotechnology, including its history, principles, and applications in various fields such as medicine, agriculture, and environmental science. CRISPR Technology: In-depth exploration of CRISPR-Cas9 technology, covering its discovery, mechanisms, and applications in genome editing, gene therapy, disease modeling, and beyond. Ethical and Regulatory Considerations: Discussion of the ethical implications of CRISPR technology, including concerns related to gene editing in humans, environmental risks, and social justice issues. Also, exploration of regulatory frameworks governing the use of CRISPR in different countries. Biotechnological Applications: Examination of biotechnological applications of CRISPR beyond genome editing, including CRISPR-based diagnostics, drug discovery, synthetic biology, and bioproduction of valuable compounds. Future Directions and Challenges: Analysis of emerging trends and future directions in biotechnology, with a focus on the potential of CRISPR technology to revolutionize healthcare, agriculture, and other industries. Also, discussion of challenges and limitations that need to be addressed for the responsible and beneficial use of CRISPR.